These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24445755)

  • 1. A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse.
    Rusz J; Megrelishvili M; Bonnet C; Okujava M; Brožová H; Khatiashvili I; Sekhniashvili M; Janelidze M; Tolosa E; Růžička E
    J Neural Transm (Vienna); 2014 Jun; 121(6):655-64. PubMed ID: 24445755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse.
    Selikhova M; Tripoliti E; Fedoryshyn L; Matvienko Y; Stanetska H; Boychuk M; Komnatska I; Lees AJ; Sanotsky Y
    Clin Neurol Neurosurg; 2016 Aug; 147():71-7. PubMed ID: 27310289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral diadochokinetic markers of X-linked dystonia-parkinsonism.
    Kao TH; Rowe HP; Green JR; Stipancic KL; Sharma N; de Guzman JK; Supnet-Wells ML; Acuna P; Perry BJ
    Parkinsonism Relat Disord; 2024 Mar; 120():105991. PubMed ID: 38184995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganic encephalopathy due to "ephedrone" abuse.
    Sanotsky Y; Lesyk R; Fedoryshyn L; Komnatska I; Matviyenko Y; Fahn S
    Mov Disord; 2007 Jul; 22(9):1337-43. PubMed ID: 17566121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.
    Selikhova M; Fedoryshyn L; Matviyenko Y; Komnatska I; Kyrylchuk M; Krolicki L; Friedman A; Taylor A; Jäger HR; Lees A; Sanotsky Y
    Mov Disord; 2008 Nov; 23(15):2224-31. PubMed ID: 18785245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological Findings in Ephedrone Encephalopathy.
    Sanotsky Y; Selikhova M; Fedoryshyn L; Kuzyk P; Matviyenko Y; Semeryak O; Dziewulska D; Holton JL; Lees AJ
    Mov Disord; 2020 Oct; 35(10):1858-1863. PubMed ID: 32542919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
    Pérez Errazquin F; Gomez Heredia MJ
    Neurologia; 2012 Apr; 27(3):181-3. PubMed ID: 21570743
    [No Abstract]   [Full Text] [Related]  

  • 8. Dualistic effect of pallidal deep brain stimulation on motor speech disorders in dystonia.
    Rusz J; Tykalová T; Fečíková A; Šťastná D; Urgošík D; Jech R
    Brain Stimul; 2018; 11(4):896-903. PubMed ID: 29576500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation-induced parkinsonism after posteroventral deep brain stimulation of the globus pallidus internus for craniocervical dystonia.
    Zauber SE; Watson N; Comella CL; Bakay RA; Metman LV
    J Neurosurg; 2009 Feb; 110(2):229-33. PubMed ID: 18976055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hyperkinetic syndrome due to ephedrone abuse.
    Dolgan A; Budrewicz S; Koszewicz M; Bladowska J; Slotwinski K; Zagrajek M; Koziorowska-Gawron E; Podemski R
    J Addict Med; 2015; 9(3):244-5. PubMed ID: 25835774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.
    de Bie RM; Gladstone RM; Strafella AP; Ko JH; Lang AE
    Arch Neurol; 2007 Jun; 64(6):886-9. PubMed ID: 17562938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism.
    Djamshidian A; Sanotsky Y; Matviyenko Y; O'Sullivan SS; Sharman S; Selikhova M; Fedoryshyn L; Filts Y; Bearn J; Lees AJ; Averbeck BB
    Addiction; 2013 Apr; 108(4):771-9. PubMed ID: 23228208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acoustic, perceptual and clinical correlates of speech and voice in isolated dystonia: Preliminary findings.
    Cuartero MC; Bertrand R; Rauzy S; Véron-Delor L; Atkinson-Clement C; Grabli D; Vidailhet M; Pinto S
    Int J Lang Commun Disord; 2021 Nov; 56(6):1204-1217. PubMed ID: 34383363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
    Kowalska-Taczanowska R; Friedman A; Koziorowski D
    Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy.
    Rusz J; Tykalová T; Salerno G; Bancone S; Scarpelli J; Pellecchia MT
    J Neurol; 2019 Jun; 266(6):1394-1404. PubMed ID: 30859316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome.
    Juurmaa J; Menke RA; Vila P; Müürsepp A; Tomberg T; Ilves P; Nigul M; Johansen-Berg H; Donaghy M; Stagg CJ; Stepens A; Taba P
    Brain Behav; 2016 Nov; 6(11):e00539. PubMed ID: 27843694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye movements in ephedrone-induced parkinsonism.
    Bonnet C; Rusz J; Megrelishvili M; Sieger T; Matoušková O; Okujava M; Brožová H; Nikolai T; Hanuška J; Kapianidze M; Mikeladze N; Botchorishvili N; Khatiashvili I; Janelidze M; Serranová T; Fiala O; Roth J; Bergquist J; Jech R; Rivaud-Péchoux S; Gaymard B; Růžička E
    PLoS One; 2014; 9(8):e104784. PubMed ID: 25117825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pallidal deep-brain stimulation on articulation rate in dystonia.
    Rusz J; Fečíková A; Tykalová T; Jech R
    Neurol Sci; 2019 Apr; 40(4):869-873. PubMed ID: 30623266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure.
    Sikk K; Taba P; Haldre S; Bergquist J; Nyholm D; Askmark H; Danfors T; Sörensen J; Thurfjell L; Raininko R; Eriksson R; Flink R; Färnstrand C; Aquilonius SM
    Acta Neurol Scand; 2010 Apr; 121(4):237-43. PubMed ID: 20028341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.